What is Pulsed Field Ablation (PFA)? PFA is a non-thermal ablation technique that uses electrical pulses to target and destroy abnormal heart tissue causing atrial fibrillation, without damaging surrounding structures like the esophagus or phrenic nerve. 👉 Faster procedures 👉 Safer for adjacent tissues 👉 Promising outcomes in early trials While RF and cryoablation rely on heat or cold, PFA works at the cellular level using electroporation. As trials expand and more data roll in, PFA is quickl

Electrophysiologist Dr. Jagmeet Singh explains how Baroreflex Activation Therapy modulates autonomic balance in patients with heart failure. The full expert discussion is now available on the MedicalVisual Clinician Hub, where clinicians explore concise device explainers, hear real-world insights from leading experts, and join conversations with clinicians across the EP and other cardiometabolic spaces. Watch the full discussion on the MedicalVisual Clinician Hub: hcp.medicalvisual.com #HeartFai

The Visual Pathway: Neuroanatomy Video Lab - Brain Dissections

When is cardioversion safe after left atrial appendage closure? Electrophysiologist Dr. Andrea Natale reviews how experienced clinicians approach cardioversion in patients with LAA occlusion devices, focusing on device seating, peri-device leak, and the absence of device-related thrombus. The discussion highlights how real-world decision-making often extends beyond binary guideline thresholds and into careful imaging review and patient-specific context. The full conversation is available on the

International Symposium on Left Atrial Appendage 2026

Join colleagues in Los Angeles, CA on March 6–7 for the 14th Annual International Symposium on Left Atrial Appendage (ISLAA) 2026. This two-day conference brings together leaders in electrophysiology and cardiovascular care to examine evolving science and procedural strategy in left atrial appendage management. The program focuses on real-world clinical decision points, from advanced intraprocedural imaging and LAAO workflows to emerging device technologies currently under clinical evaluation. D